Anti-Human IFNA1 Recombinant Antibody(Sifalimumab)
-
产品编号
YR1217
-
别名
科研级 Sifalimumab ( 西法木单抗 ), Anti-IFNA1 Recombinant Antibody, Research Grade Sifalimumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Sifalimumab ( 西法木单抗 ), Anti-IFNA1 Recombinant Antibody, Research Grade Sifalimumab |
| Catalog Number | YR1217 |
| Molecular Name | Sifalimumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Sifalimumab is a human monoclonal antibody designed for the treatment of SLE, dermatomyositis, and polymyositis. It targets interferon a. Sifalimumab was developed by MedImmune, as of 2017 development had been terminated in favor of moving a competing internal product, anifrolumab, into Phase III trials. |
| CAS Number | 1006877-41-3 |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | IFNA1[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
